Choosing a manufacturing partner has been one of our most important tasks at Dtablet. It has been a long and thorough process. Since June 2025, we have been in discussions with five potential manufacturers and conducted an extensive evaluation of each.
We made our final choice in November 2025 and have maintained close and regular contact with the manufacturer ever since.
An important factor in our decision was that our chairman already knew the company as a high-quality manufacturer and had established contacts there. The manufacturer also has extensive expertise in mechanical engineering, electronics, software and firmware. Combined with a well-established partner network and its own factory for final assembly and production, this makes it a strong partner for both the development and manufacturing of Dtablet.
The collaboration has been excellent. The manufacturer has developed functional prototypes, with particular attention to component selection, materials, design for manufacturing and thorough quality control.
In September, chairman Bjørn Åge Brandal, investor Thomas Ulleberg and CEO Hallgrim Bjørvik visited the factory. We toured the production facilities and spent valuable time with the team testing and refining the functional prototypes.
The manufacturer has also worked closely with industrial designer Carl-Gustaf Lundholm at Kadabra, who has helped preserve the original design vision and review the technical solutions selected by the manufacturer.
For us, it was important to finalise all key product decisions before signing the agreement and to be confident that the manufacturer had the expertise and capability to develop effective solutions in close collaboration with us.
We have also spent considerable time reviewing and discussing timelines and costs for both development and manufacturing. Throughout the process, we have shared one goal: to develop a product that makes everyday life easier for people who take medication.
We are therefore delighted to announce that the development and manufacturing agreement has now been signed!
With the agreement in place, we are moving forward with developing and completing the production tooling, further testing and quality assurance, and preparations for mass production.
We look forward to bringing Dtablet to market!
Would you like to be among the first to use Dtablet? Join the waiting list here.
Dtablet was born out of founder Hallgrim Bjørvik’s own needs. The need for a simpler and safer way to manage medication has since been confirmed by a survey conducted by Ipsos on behalf of Dtablet.